Navigation Links
RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants
Date:11/9/2012

International African Vaccinology Conference, Cape Town, South AfricaResults from a pivotal, large-scale Phase III trial, published online today in the New England Journal of Medicine, show that the RTS,S malaria vaccine candidate can help protect African infants against malaria. When compared to immunization with a control vaccine, infants (aged 6-12 weeks at first vaccination) vaccinated with RTS,S had one-third fewer episodes of both clinical and severe malaria and had similar reactions to the injection. In this trial, RTS,S demonstrated an acceptable safety and tolerability profile.

Eleven African research centres in seven African countries [1] are conducting this trial, together with GlaxoSmithKline (GSK) and the PATH Malaria Vaccine Initiative (MVI), with grant funding from the Bill & Melinda Gates Foundation to MVI.

Dr. Salim Abdulla, a principal investigator for the trial from the Ifakara Health Institute, Tanzania, said: "We've made significant progress in recent years in our battle against malaria, but the disease still kills 655,000 people a yearmainly children under five in sub-Saharan Africa. An effective malaria vaccine would be a welcome addition to our tool kit, and we've been working toward this goal with this RTS,S trial. This study indicates that RTS,S can help to protect young babies against malaria. Importantly, we observed that it provided this protection in addition to the widespread use of bed nets by the trial participants."

Efficacy

When administered along with standard childhood vaccines,[2] the efficacy of RTS,S in infants aged 6 to 12 weeks (at first vaccination) against clinical and severe malaria was 31% and 37%,[3] respectively, over 12 months of follow-up after the third vaccine dose.[4] Insecticide-treated bed nets were used by 86% of the trial participants, which demonstrated that RTS,S provided protection beyond existing malaria control interventions. The efficacy observed with RT
'/>"/>

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Burness Communications
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Notre Dame researchers using novel method to combat malaria drug resistance
2. Scientists find Achilles heel in life-threatening malaria parasites
3. Drug could reverse scourge of cerebral malaria for survivors
4. Game on! UCLA researchers use online crowd-sourcing to diagnose malaria
5. African scientist, designer partner to fashion anti-malaria garment that wards off bugs
6. Considerable prevalence of both malaria, STIs exist among pregnant women in sub-Saharan Africa
7. New discoveries about severe malaria
8. New book tells story of 10-year-old malaria project
9. MMV develops framework to assess risk of resistance for antimalarial compounds
10. African research identifies strong candidate for possible single-dose malaria cure
11. WSU/USDA scientist creates test, treatment for malaria-like sickness in horses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 19, 2014  Earlier this year Donald Spector ... and one of the most prolific inventors in the ... transmitted from Smartphones to third party agencies. Spector envisioned ... one of the earliest known patents in this area. ... the military, child care, elder care and hospital applications. ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... BETHESDA, Md. , Nov. 17, 2014 The ... European and U.S. regulatory agencies will speak and at least ... Quality Metrics Conference at the Omni Shoreham Hotel in ... is pleased once again to have significant support from the ... and Europe in our effort to ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... ... N.Y. and FOOTHILL RANCH, Calif., Dec. 17 IBM ( ... new security solution that integrates palm vein biometric technology from Fujitsu ... http://www.newscom.com/cgi-bin/prnh/20091217/NY27736 ) , (Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO ) , The ...
... has announced the winners of its student travel award ... the Moscone Convention Center in San Francisco, California, February ... selected based on scientific merit, with priority given to ... Each awardee receives a travel grant and will ...
... Athletes, superstitions and rituals can help them get ... non-steroidal anti-inflammatory drugs (NSAIDs), which many athletes gobble down ... harm than good. "These agents are treatments for ... says Stuart Warden, whose research at Indiana University focuses ...
Cached Biology News:Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 2Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 3Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 4Fujitsu and IBM Offer Biometric Security Solution That Replaces Passwords With the Scan of an Employee's Palm 5Biophysical Society announces winners of 2010 Student Travel Awards 2Biophysical Society announces winners of 2010 Student Travel Awards 3Biophysical Society announces winners of 2010 Student Travel Awards 4NSAIDs: Take 'em early and often when competing? Think again 2
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... meal if certain protein components are experimentally disrupted, a ... discovered. The approach could be used as an ... diseases like dengue fever, yellow fever and malaria. ... vesicle transport, on which the mosquitoes rely to release ...
... on the buttock or the delicately soft entry of a blood ... "how" to use those tiny "molecular syringes" which are carbon nanotubes. ... (nanometre) and a maximum length of just a few millimetres, the ... ethereal tubes - the smallest ever made by man - is ...
... LOS ANGELES, July 18, 2011 Genesis Biopharma, Inc. ... today announced it has named David Voyticky to its ... Miller Energy Resources (NYSE: MILL ), an ... 16 years of experience in corporate finance and merger ...
Cached Biology Technology:Making blood-sucking deadly for mosquitoes 2Making blood-sucking deadly for mosquitoes 3Making blood-sucking deadly for mosquitoes 4Nanotech: injections or sampling? New 'molecular syringes' under testing 2Genesis Biopharma Names David Voyticky to Board of Directors 2
... ProteinChip System, Series 4000 incorporates the critical ... and biologists in biomarker research. The Series ... route for converting biomarker discoveries to biomarker ... Series 4000 is designed to fit into ...
Gelatin 100 mm Culture Dishes...
BD Primaria 100 mm Cell Culture Dish, surface-modified polystyrene for enhanced cell culture. (200/ca) Packaging: 20 / sleeve, 200 / case ...
...
Biology Products: